Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Operating Margin (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Operating Margin for 6 consecutive years, with 866.14% as the latest value for Q4 2025.

  • Quarterly Operating Margin changed N/A to 866.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1971.46% through Dec 2025, up 175062.0% year-over-year, with the annual reading at 1971.59% for FY2025, 175048.0% up from the prior year.
  • Operating Margin for Q4 2025 was 866.14% at Relay Therapeutics, up from 11351.11% in the prior quarter.
  • The five-year high for Operating Margin was 9219600.0% in Q4 2023, with the low at 89117.65% in Q2 2023.
  • Average Operating Margin over 5 years is 558290.85%, with a median of 11647.6% recorded in 2021.
  • The sharpest move saw Operating Margin crashed -94690269bps in 2021, then soared 924839486bps in 2023.
  • Over 5 years, Operating Margin stood at 11944.09% in 2021, then crashed by -141bps to 28794.86% in 2022, then surged by 32118bps to 9219600.0% in 2023, then tumbled by -100bps to 903.0% in 2024, then increased by 4bps to 866.14% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 866.14%, 11351.11%, and 1105.21% for Q4 2025, Q2 2025, and Q1 2025 respectively.